Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Drugs for Osteoarthritis Pain Sales Market Report 2017

  • QYR1188064
  • 120 Pages
  • May 2017
  • Pharmaceuticals
Download Sample    Get Discount   
 
In this report, the global Drugs for Osteoarthritis Pain market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Drugs for Osteoarthritis Pain for these regions, from 2012 to 2022 (forecast), covering

United States

China

Europe

Japan

Southeast Asia

India

Global Drugs for Osteoarthritis Pain market competition by top manufacturers/players, with Drugs for Osteoarthritis Pain sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

Abbott Laboratories

Johnson & Johnson

Novartis International

Pfizer

AbbVie

Abiogen Pharma

Afferent Pharmaceuticals

Astellas Pharma

BioDelivery Sciences International

Crystal Genomics

Cytori Therapeutics

Daiichi Sankyo

Eli Lilly

Endo Pharmaceuticals Holdings

Horizon Pharma

iCeutica

Iroko Pharmaceuticals

Merck

Nuvo Research

Regeneron Pharmaceuticals

Sanofi

SantoSolve

Techfields Pharma

Winston Pharmaceuticals

Yooyoung Pharmaceutical

Zynerba Pharmaceuticals

On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into

Solid

Liquid

Semi-solid

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Drugs for Osteoarthritis Pain for each application, including

Oral

Injection

External

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Global Drugs for Osteoarthritis Pain Sales Market Report 2017

1 Drugs for Osteoarthritis Pain Market Overview

1.1 Product Overview and Scope of Drugs for Osteoarthritis Pain

1.2 Classification of Drugs for Osteoarthritis Pain by Product Category

1.2.1 Global Drugs for Osteoarthritis Pain Market Size (Sales) Comparison by Type (2012-2022)

1.2.2 Global Drugs for Osteoarthritis Pain Market Size (Sales) Market Share by Type (Product Category) in 2016

1.2.3 Solid

1.2.4 Liquid

1.2.5 Semi-solid

1.3 Global Drugs for Osteoarthritis Pain Market by Application/End Users

1.3.1 Global Drugs for Osteoarthritis Pain Sales (Volume) and Market Share Comparison by Application (2012-2022)

1.3.2 Oral

1.3.3 Injection

1.3.4 External

1.4 Global Drugs for Osteoarthritis Pain Market by Region

1.4.1 Global Drugs for Osteoarthritis Pain Market Size (Value) Comparison by Region (2012-2022)

1.4.2 United States Drugs for Osteoarthritis Pain Status and Prospect (2012-2022)

1.4.3 China Drugs for Osteoarthritis Pain Status and Prospect (2012-2022)

1.4.4 Europe Drugs for Osteoarthritis Pain Status and Prospect (2012-2022)

1.4.5 Japan Drugs for Osteoarthritis Pain Status and Prospect (2012-2022)

1.4.6 Southeast Asia Drugs for Osteoarthritis Pain Status and Prospect (2012-2022)

1.4.7 India Drugs for Osteoarthritis Pain Status and Prospect (2012-2022)

1.5 Global Market Size (Value and Volume) of Drugs for Osteoarthritis Pain (2012-2022)

1.5.1 Global Drugs for Osteoarthritis Pain Sales and Growth Rate (2012-2022)

1.5.2 Global Drugs for Osteoarthritis Pain Revenue and Growth Rate (2012-2022)

2 Global Drugs for Osteoarthritis Pain Competition by Players/Suppliers, Type and Application

2.1 Global Drugs for Osteoarthritis Pain Market Competition by Players/Suppliers

2.1.1 Global Drugs for Osteoarthritis Pain Sales and Market Share of Key Players/Suppliers (2012-2017)

2.1.2 Global Drugs for Osteoarthritis Pain Revenue and Share by Players/Suppliers (2012-2017)

2.2 Global Drugs for Osteoarthritis Pain (Volume and Value) by Type

2.2.1 Global Drugs for Osteoarthritis Pain Sales and Market Share by Type (2012-2017)

2.2.2 Global Drugs for Osteoarthritis Pain Revenue and Market Share by Type (2012-2017)

2.3 Global Drugs for Osteoarthritis Pain (Volume and Value) by Region

2.3.1 Global Drugs for Osteoarthritis Pain Sales and Market Share by Region (2012-2017)

2.3.2 Global Drugs for Osteoarthritis Pain Revenue and Market Share by Region (2012-2017)

2.4 Global Drugs for Osteoarthritis Pain (Volume) by Application

3 United States Drugs for Osteoarthritis Pain (Volume, Value and Sales Price)

3.1 United States Drugs for Osteoarthritis Pain Sales and Value (2012-2017)

3.1.1 United States Drugs for Osteoarthritis Pain Sales and Growth Rate (2012-2017)

3.1.2 United States Drugs for Osteoarthritis Pain Revenue and Growth Rate (2012-2017)

3.1.3 United States Drugs for Osteoarthritis Pain Sales Price Trend (2012-2017)

3.2 United States Drugs for Osteoarthritis Pain Sales Volume and Market Share by Players

3.3 United States Drugs for Osteoarthritis Pain Sales Volume and Market Share by Type

3.4 United States Drugs for Osteoarthritis Pain Sales Volume and Market Share by Application

4 China Drugs for Osteoarthritis Pain (Volume, Value and Sales Price)

4.1 China Drugs for Osteoarthritis Pain Sales and Value (2012-2017)

4.1.1 China Drugs for Osteoarthritis Pain Sales and Growth Rate (2012-2017)

4.1.2 China Drugs for Osteoarthritis Pain Revenue and Growth Rate (2012-2017)

4.1.3 China Drugs for Osteoarthritis Pain Sales Price Trend (2012-2017)

4.2 China Drugs for Osteoarthritis Pain Sales Volume and Market Share by Players

4.3 China Drugs for Osteoarthritis Pain Sales Volume and Market Share by Type

4.4 China Drugs for Osteoarthritis Pain Sales Volume and Market Share by Application

5 Europe Drugs for Osteoarthritis Pain (Volume, Value and Sales Price)

5.1 Europe Drugs for Osteoarthritis Pain Sales and Value (2012-2017)

5.1.1 Europe Drugs for Osteoarthritis Pain Sales and Growth Rate (2012-2017)

5.1.2 Europe Drugs for Osteoarthritis Pain Revenue and Growth Rate (2012-2017)

5.1.3 Europe Drugs for Osteoarthritis Pain Sales Price Trend (2012-2017)

5.2 Europe Drugs for Osteoarthritis Pain Sales Volume and Market Share by Players

5.3 Europe Drugs for Osteoarthritis Pain Sales Volume and Market Share by Type

5.4 Europe Drugs for Osteoarthritis Pain Sales Volume and Market Share by Application

6 Japan Drugs for Osteoarthritis Pain (Volume, Value and Sales Price)

6.1 Japan Drugs for Osteoarthritis Pain Sales and Value (2012-2017)

6.1.1 Japan Drugs for Osteoarthritis Pain Sales and Growth Rate (2012-2017)

6.1.2 Japan Drugs for Osteoarthritis Pain Revenue and Growth Rate (2012-2017)

6.1.3 Japan Drugs for Osteoarthritis Pain Sales Price Trend (2012-2017)

6.2 Japan Drugs for Osteoarthritis Pain Sales Volume and Market Share by Players

6.3 Japan Drugs for Osteoarthritis Pain Sales Volume and Market Share by Type

6.4 Japan Drugs for Osteoarthritis Pain Sales Volume and Market Share by Application

7 Southeast Asia Drugs for Osteoarthritis Pain (Volume, Value and Sales Price)

7.1 Southeast Asia Drugs for Osteoarthritis Pain Sales and Value (2012-2017)

7.1.1 Southeast Asia Drugs for Osteoarthritis Pain Sales and Growth Rate (2012-2017)

7.1.2 Southeast Asia Drugs for Osteoarthritis Pain Revenue and Growth Rate (2012-2017)

7.1.3 Southeast Asia Drugs for Osteoarthritis Pain Sales Price Trend (2012-2017)

7.2 Southeast Asia Drugs for Osteoarthritis Pain Sales Volume and Market Share by Players

7.3 Southeast Asia Drugs for Osteoarthritis Pain Sales Volume and Market Share by Type

7.4 Southeast Asia Drugs for Osteoarthritis Pain Sales Volume and Market Share by Application

8 India Drugs for Osteoarthritis Pain (Volume, Value and Sales Price)

8.1 India Drugs for Osteoarthritis Pain Sales and Value (2012-2017)

8.1.1 India Drugs for Osteoarthritis Pain Sales and Growth Rate (2012-2017)

8.1.2 India Drugs for Osteoarthritis Pain Revenue and Growth Rate (2012-2017)

8.1.3 India Drugs for Osteoarthritis Pain Sales Price Trend (2012-2017)

8.2 India Drugs for Osteoarthritis Pain Sales Volume and Market Share by Players

8.3 India Drugs for Osteoarthritis Pain Sales Volume and Market Share by Type

8.4 India Drugs for Osteoarthritis Pain Sales Volume and Market Share by Application

9 Global Drugs for Osteoarthritis Pain Players/Suppliers Profiles and Sales Data

9.1 Abbott Laboratories

9.1.1 Company Basic Information, Manufacturing Base and Competitors

9.1.2 Drugs for Osteoarthritis Pain Product Category, Application and Specification

9.1.2.1 Product A

9.1.2.2 Product B

9.1.3 Abbott Laboratories Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2012-2017)

9.1.4 Main Business/Business Overview

9.2 Johnson & Johnson

9.2.1 Company Basic Information, Manufacturing Base and Competitors

9.2.2 Drugs for Osteoarthritis Pain Product Category, Application and Specification

9.2.2.1 Product A

9.2.2.2 Product B

9.2.3 Johnson & Johnson Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2012-2017)

9.2.4 Main Business/Business Overview

9.3 Novartis International

9.3.1 Company Basic Information, Manufacturing Base and Competitors

9.3.2 Drugs for Osteoarthritis Pain Product Category, Application and Specification

9.3.2.1 Product A

9.3.2.2 Product B

9.3.3 Novartis International Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2012-2017)

9.3.4 Main Business/Business Overview

9.4 Pfizer

9.4.1 Company Basic Information, Manufacturing Base and Competitors

9.4.2 Drugs for Osteoarthritis Pain Product Category, Application and Specification

9.4.2.1 Product A

9.4.2.2 Product B

9.4.3 Pfizer Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2012-2017)

9.4.4 Main Business/Business Overview

9.5 AbbVie

9.5.1 Company Basic Information, Manufacturing Base and Competitors

9.5.2 Drugs for Osteoarthritis Pain Product Category, Application and Specification

9.5.2.1 Product A

9.5.2.2 Product B

9.5.3 AbbVie Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2012-2017)

9.5.4 Main Business/Business Overview

9.6 Abiogen Pharma

9.6.1 Company Basic Information, Manufacturing Base and Competitors

9.6.2 Drugs for Osteoarthritis Pain Product Category, Application and Specification

9.6.2.1 Product A

9.6.2.2 Product B

9.6.3 Abiogen Pharma Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2012-2017)

9.6.4 Main Business/Business Overview

9.7 Afferent Pharmaceuticals

9.7.1 Company Basic Information, Manufacturing Base and Competitors

9.7.2 Drugs for Osteoarthritis Pain Product Category, Application and Specification

9.7.2.1 Product A

9.7.2.2 Product B

9.7.3 Afferent Pharmaceuticals Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2012-2017)

9.7.4 Main Business/Business Overview

9.8 Astellas Pharma

9.8.1 Company Basic Information, Manufacturing Base and Competitors

9.8.2 Drugs for Osteoarthritis Pain Product Category, Application and Specification

9.8.2.1 Product A

9.8.2.2 Product B

9.8.3 Astellas Pharma Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2012-2017)

9.8.4 Main Business/Business Overview

9.9 BioDelivery Sciences International

9.9.1 Company Basic Information, Manufacturing Base and Competitors

9.9.2 Drugs for Osteoarthritis Pain Product Category, Application and Specification

9.9.2.1 Product A

9.9.2.2 Product B

9.9.3 BioDelivery Sciences International Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2012-2017)

9.9.4 Main Business/Business Overview

9.10 Crystal Genomics

9.10.1 Company Basic Information, Manufacturing Base and Competitors

9.10.2 Drugs for Osteoarthritis Pain Product Category, Application and Specification

9.10.2.1 Product A

9.10.2.2 Product B

9.10.3 Crystal Genomics Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2012-2017)

9.10.4 Main Business/Business Overview

9.11 Cytori Therapeutics

9.12 Daiichi Sankyo

9.13 Eli Lilly

9.14 Endo Pharmaceuticals Holdings

9.15 Horizon Pharma

9.16 iCeutica

9.17 Iroko Pharmaceuticals

9.18 Merck

9.19 Nuvo Research

9.20 Regeneron Pharmaceuticals

9.21 Sanofi

9.22 SantoSolve

9.23 Techfields Pharma

9.24 Winston Pharmaceuticals

9.25 Yooyoung Pharmaceutical

9.26 Zynerba Pharmaceuticals

10 Drugs for Osteoarthritis Pain Maufacturing Cost Analysis

10.1 Drugs for Osteoarthritis Pain Key Raw Materials Analysis

10.1.1 Key Raw Materials

10.1.2 Price Trend of Key Raw Materials

10.1.3 Key Suppliers of Raw Materials

10.1.4 Market Concentration Rate of Raw Materials

10.2 Proportion of Manufacturing Cost Structure

10.2.1 Raw Materials

10.2.2 Labor Cost

10.2.3 Manufacturing Process Analysis of Drugs for Osteoarthritis Pain

10.3 Manufacturing Process Analysis of Drugs for Osteoarthritis Pain

11 Industrial Chain, Sourcing Strategy and Downstream Buyers

11.1 Drugs for Osteoarthritis Pain Industrial Chain Analysis

11.2 Upstream Raw Materials Sourcing

11.3 Raw Materials Sources of Drugs for Osteoarthritis Pain Major Manufacturers in 2016

11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders

12.1 Marketing Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.1.3 Marketing Channel Development Trend

12.2 Market Positioning

12.2.1 Pricing Strategy

12.2.2 Brand Strategy

12.2.3 Target Client

12.3 Distributors/Traders List

13 Market Effect Factors Analysis

13.1 Technology Progress/Risk

13.1.1 Substitutes Threat

13.1.2 Technology Progress in Related Industry

13.2 Consumer Needs/Customer Preference Change

13.3 Economic/Political Environmental Change

14 Global Drugs for Osteoarthritis Pain Market Forecast (2017-2022)

14.1 Global Drugs for Osteoarthritis Pain Sales Volume, Revenue and Price Forecast (2017-2022)

14.1.1 Global Drugs for Osteoarthritis Pain Sales Volume and Growth Rate Forecast (2017-2022)

14.1.2 Global Drugs for Osteoarthritis Pain Revenue and Growth Rate Forecast (2017-2022)

14.1.3 Global Drugs for Osteoarthritis Pain Price and Trend Forecast (2017-2022)

14.2 Global Drugs for Osteoarthritis Pain Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)

14.2.1 Global Drugs for Osteoarthritis Pain Sales Volume and Growth Rate Forecast by Regions (2017-2022)

14.2.2 Global Drugs for Osteoarthritis Pain Revenue and Growth Rate Forecast by Regions (2017-2022)

14.2.3 United States Drugs for Osteoarthritis Pain Sales Volume, Revenue and Growth Rate Forecast (2017-2022)

14.2.4 China Drugs for Osteoarthritis Pain Sales Volume, Revenue and Growth Rate Forecast (2017-2022)

14.2.5 Europe Drugs for Osteoarthritis Pain Sales Volume, Revenue and Growth Rate Forecast (2017-2022)

14.2.6 Japan Drugs for Osteoarthritis Pain Sales Volume, Revenue and Growth Rate Forecast (2017-2022)

14.2.7 Southeast Asia Drugs for Osteoarthritis Pain Sales Volume, Revenue and Growth Rate Forecast (2017-2022)

14.2.8 India Drugs for Osteoarthritis Pain Sales Volume, Revenue and Growth Rate Forecast (2017-2022)

14.3 Global Drugs for Osteoarthritis Pain Sales Volume, Revenue and Price Forecast by Type (2017-2022)

14.3.1 Global Drugs for Osteoarthritis Pain Sales Forecast by Type (2017-2022)

14.3.2 Global Drugs for Osteoarthritis Pain Revenue Forecast by Type (2017-2022)

14.3.3 Global Drugs for Osteoarthritis Pain Price Forecast by Type (2017-2022)

14.4 Global Drugs for Osteoarthritis Pain Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology/Research Approach

16.1.1 Research Programs/Design

16.1.2 Market Size Estimation

16.1.3 Market Breakdown and Data Triangulation

16.2 Data Source

16.2.1 Secondary Sources

16.2.2 Primary Sources

16.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Drugs for Osteoarthritis Pain

Figure Global Drugs for Osteoarthritis Pain Sales Volume Comparison (K Pcs) by Type (2012-2022)

Figure Global Drugs for Osteoarthritis Pain Sales Volume Market Share by Type (Product Category) in 2016

Figure Solid Product Picture

Figure Liquid Product Picture

Figure Semi-solid Product Picture

Figure Global Drugs for Osteoarthritis Pain Sales Comparison (K Pcs) by Application (2012-2022)

Figure Global Sales Market Share of Drugs for Osteoarthritis Pain by Application in 2016

Figure Oral Examples

Figure Injection Examples

Figure External Examples

Figure Global Drugs for Osteoarthritis Pain Market Size (Million USD) by Regions (2012-2022)

Figure United States Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2012-2022)

Figure China Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2012-2022)

Figure Europe Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2012-2022)

Figure Japan Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southeast Asia Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2012-2022)

Figure India Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2012-2022)

Figure Global Drugs for Osteoarthritis Pain Sales Volume (K Pcs) and Growth Rate (2012-2022)

Figure Global Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2012-2022)

Figure Global Market Major Players Drugs for Osteoarthritis Pain Sales Volume (K Pcs) (2012-2017)

Table Global Drugs for Osteoarthritis Pain Sales (K Pcs) of Key Players/Suppliers (2012-2017)

Table Global Drugs for Osteoarthritis Pain Sales Share by Players/Suppliers (2012-2017)

Figure 2016 Drugs for Osteoarthritis Pain Sales Share by Players/Suppliers

Figure 2017 Drugs for Osteoarthritis Pain Sales Share by Players/Suppliers

Figure Global Drugs for Osteoarthritis Pain Revenue (Million USD) by Players/Suppliers (2012-2017)

Table Global Drugs for Osteoarthritis Pain Revenue (Million USD) by Players/Suppliers (2012-2017)

Table Global Drugs for Osteoarthritis Pain Revenue Share by Players/Suppliers (2012-2017)

Table 2016 Global Drugs for Osteoarthritis Pain Revenue Share by Players

Table 2017 Global Drugs for Osteoarthritis Pain Revenue Share by Players

Table Global Drugs for Osteoarthritis Pain Sales (K Pcs) and Market Share by Type (2012-2017)

Table Global Drugs for Osteoarthritis Pain Sales Share (K Pcs) by Type (2012-2017)

Figure Sales Market Share of Drugs for Osteoarthritis Pain by Type (2012-2017)

Figure Global Drugs for Osteoarthritis Pain Sales Growth Rate by Type (2012-2017)

Table Global Drugs for Osteoarthritis Pain Revenue (Million USD) and Market Share by Type (2012-2017)

Table Global Drugs for Osteoarthritis Pain Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Drugs for Osteoarthritis Pain by Type (2012-2017)

Figure Global Drugs for Osteoarthritis Pain Revenue Growth Rate by Type (2012-2017)

Table Global Drugs for Osteoarthritis Pain Sales Volume (K Pcs) and Market Share by Region (2012-2017)

Table Global Drugs for Osteoarthritis Pain Sales Share by Region (2012-2017)

Figure Sales Market Share of Drugs for Osteoarthritis Pain by Region (2012-2017)

Figure Global Drugs for Osteoarthritis Pain Sales Growth Rate by Region in 2016

Table Global Drugs for Osteoarthritis Pain Revenue (Million USD) and Market Share by Region (2012-2017)

Table Global Drugs for Osteoarthritis Pain Revenue Share (%) by Region (2012-2017)

Figure Revenue Market Share of Drugs for Osteoarthritis Pain by Region (2012-2017)

Figure Global Drugs for Osteoarthritis Pain Revenue Growth Rate by Region in 2016

Table Global Drugs for Osteoarthritis Pain Revenue (Million USD) and Market Share by Region (2012-2017)

Table Global Drugs for Osteoarthritis Pain Revenue Share (%) by Region (2012-2017)

Figure Revenue Market Share of Drugs for Osteoarthritis Pain by Region (2012-2017)

Figure Global Drugs for Osteoarthritis Pain Revenue Market Share by Region in 2016

Table Global Drugs for Osteoarthritis Pain Sales Volume (K Pcs) and Market Share by Application (2012-2017)

Table Global Drugs for Osteoarthritis Pain Sales Share (%) by Application (2012-2017)

Figure Sales Market Share of Drugs for Osteoarthritis Pain by Application (2012-2017)

Figure Global Drugs for Osteoarthritis Pain Sales Market Share by Application (2012-2017)

Figure United States Drugs for Osteoarthritis Pain Sales (K Pcs) and Growth Rate (2012-2017)

Figure United States Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2012-2017)

Figure United States Drugs for Osteoarthritis Pain Sales Price (USD/Pcs) Trend (2012-2017)

Table United States Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Players (2012-2017)

Table United States Drugs for Osteoarthritis Pain Sales Volume Market Share by Players (2012-2017)

Figure United States Drugs for Osteoarthritis Pain Sales Volume Market Share by Players in 2016

Table United States Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Type (2012-2017)

Table United States Drugs for Osteoarthritis Pain Sales Volume Market Share by Type (2012-2017)

Figure United States Drugs for Osteoarthritis Pain Sales Volume Market Share by Type in 2016

Table United States Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Application (2012-2017)

Table United States Drugs for Osteoarthritis Pain Sales Volume Market Share by Application (2012-2017)

Figure United States Drugs for Osteoarthritis Pain Sales Volume Market Share by Application in 2016

Figure China Drugs for Osteoarthritis Pain Sales (K Pcs) and Growth Rate (2012-2017)

Figure China Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2012-2017)

Figure China Drugs for Osteoarthritis Pain Sales Price (USD/Pcs) Trend (2012-2017)

Table China Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Players (2012-2017)

Table China Drugs for Osteoarthritis Pain Sales Volume Market Share by Players (2012-2017)

Figure China Drugs for Osteoarthritis Pain Sales Volume Market Share by Players in 2016

Table China Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Type (2012-2017)

Table China Drugs for Osteoarthritis Pain Sales Volume Market Share by Type (2012-2017)

Figure China Drugs for Osteoarthritis Pain Sales Volume Market Share by Type in 2016

Table China Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Application (2012-2017)

Table China Drugs for Osteoarthritis Pain Sales Volume Market Share by Application (2012-2017)

Figure China Drugs for Osteoarthritis Pain Sales Volume Market Share by Application in 2016

Figure Europe Drugs for Osteoarthritis Pain Sales (K Pcs) and Growth Rate (2012-2017)

Figure Europe Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2012-2017)

Figure Europe Drugs for Osteoarthritis Pain Sales Price (USD/Pcs) Trend (2012-2017)

Table Europe Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Players (2012-2017)

Table Europe Drugs for Osteoarthritis Pain Sales Volume Market Share by Players (2012-2017)

Figure Europe Drugs for Osteoarthritis Pain Sales Volume Market Share by Players in 2016

Table Europe Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Type (2012-2017)

Table Europe Drugs for Osteoarthritis Pain Sales Volume Market Share by Type (2012-2017)

Figure Europe Drugs for Osteoarthritis Pain Sales Volume Market Share by Type in 2016

Table Europe Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Application (2012-2017)

Table Europe Drugs for Osteoarthritis Pain Sales Volume Market Share by Application (2012-2017)

Figure Europe Drugs for Osteoarthritis Pain Sales Volume Market Share by Application in 2016

Figure Japan Drugs for Osteoarthritis Pain Sales (K Pcs) and Growth Rate (2012-2017)

Figure Japan Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2012-2017)

Figure Japan Drugs for Osteoarthritis Pain Sales Price (USD/Pcs) Trend (2012-2017)

Table Japan Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Players (2012-2017)

Table Japan Drugs for Osteoarthritis Pain Sales Volume Market Share by Players (2012-2017)

Figure Japan Drugs for Osteoarthritis Pain Sales Volume Market Share by Players in 2016

Table Japan Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Type (2012-2017)

Table Japan Drugs for Osteoarthritis Pain Sales Volume Market Share by Type (2012-2017)

Figure Japan Drugs for Osteoarthritis Pain Sales Volume Market Share by Type in 2016

Table Japan Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Application (2012-2017)

Table Japan Drugs for Osteoarthritis Pain Sales Volume Market Share by Application (2012-2017)

Figure Japan Drugs for Osteoarthritis Pain Sales Volume Market Share by Application in 2016

Figure Southeast Asia Drugs for Osteoarthritis Pain Sales (K Pcs) and Growth Rate (2012-2017)

Figure Southeast Asia Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2012-2017)

Figure Southeast Asia Drugs for Osteoarthritis Pain Sales Price (USD/Pcs) Trend (2012-2017)

Table Southeast Asia Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Players (2012-2017)

Table Southeast Asia Drugs for Osteoarthritis Pain Sales Volume Market Share by Players (2012-2017)

Figure Southeast Asia Drugs for Osteoarthritis Pain Sales Volume Market Share by Players in 2016

Table Southeast Asia Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Type (2012-2017)

Table Southeast Asia Drugs for Osteoarthritis Pain Sales Volume Market Share by Type (2012-2017)

Figure Southeast Asia Drugs for Osteoarthritis Pain Sales Volume Market Share by Type in 2016

Table Southeast Asia Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Application (2012-2017)

Table Southeast Asia Drugs for Osteoarthritis Pain Sales Volume Market Share by Application (2012-2017)

Figure Southeast Asia Drugs for Osteoarthritis Pain Sales Volume Market Share by Application in 2016

Figure India Drugs for Osteoarthritis Pain Sales (K Pcs) and Growth Rate (2012-2017)

Figure India Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2012-2017)

Figure India Drugs for Osteoarthritis Pain Sales Price (USD/Pcs) Trend (2012-2017)

Table India Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Players (2012-2017)

Table India Drugs for Osteoarthritis Pain Sales Volume Market Share by Players (2012-2017)

Figure India Drugs for Osteoarthritis Pain Sales Volume Market Share by Players in 2016

Table India Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Type (2012-2017)

Table India Drugs for Osteoarthritis Pain Sales Volume Market Share by Type (2012-2017)

Figure India Drugs for Osteoarthritis Pain Sales Volume Market Share by Type in 2016

Table India Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Application (2012-2017)

Table India Drugs for Osteoarthritis Pain Sales Volume Market Share by Application (2012-2017)

Figure India Drugs for Osteoarthritis Pain Sales Volume Market Share by Application in 2016

Table Abbott Laboratories Basic Information List

Table Abbott Laboratories Drugs for Osteoarthritis Pain Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Abbott Laboratories Drugs for Osteoarthritis Pain Sales Growth Rate (2012-2017)

Figure Abbott Laboratories Drugs for Osteoarthritis Pain Sales Global Market Share (2012-2017

Figure Abbott Laboratories Drugs for Osteoarthritis Pain Revenue Global Market Share (2012-2017)

Table Johnson & Johnson Basic Information List

Table Johnson & Johnson Drugs for Osteoarthritis Pain Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Johnson & Johnson Drugs for Osteoarthritis Pain Sales Growth Rate (2012-2017)

Figure Johnson & Johnson Drugs for Osteoarthritis Pain Sales Global Market Share (2012-2017

Figure Johnson & Johnson Drugs for Osteoarthritis Pain Revenue Global Market Share (2012-2017)

Table Novartis International Basic Information List

Table Novartis International Drugs for Osteoarthritis Pain Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Novartis International Drugs for Osteoarthritis Pain Sales Growth Rate (2012-2017)

Figure Novartis International Drugs for Osteoarthritis Pain Sales Global Market Share (2012-2017

Figure Novartis International Drugs for Osteoarthritis Pain Revenue Global Market Share (2012-2017)

Table Pfizer Basic Information List

Table Pfizer Drugs for Osteoarthritis Pain Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Pfizer Drugs for Osteoarthritis Pain Sales Growth Rate (2012-2017)

Figure Pfizer Drugs for Osteoarthritis Pain Sales Global Market Share (2012-2017

Figure Pfizer Drugs for Osteoarthritis Pain Revenue Global Market Share (2012-2017)

Table AbbVie Basic Information List

Table AbbVie Drugs for Osteoarthritis Pain Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure AbbVie Drugs for Osteoarthritis Pain Sales Growth Rate (2012-2017)

Figure AbbVie Drugs for Osteoarthritis Pain Sales Global Market Share (2012-2017

Figure AbbVie Drugs for Osteoarthritis Pain Revenue Global Market Share (2012-2017)

Table Abiogen Pharma Basic Information List

Table Abiogen Pharma Drugs for Osteoarthritis Pain Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Abiogen Pharma Drugs for Osteoarthritis Pain Sales Growth Rate (2012-2017)

Figure Abiogen Pharma Drugs for Osteoarthritis Pain Sales Global Market Share (2012-2017

Figure Abiogen Pharma Drugs for Osteoarthritis Pain Revenue Global Market Share (2012-2017)

Table Afferent Pharmaceuticals Basic Information List

Table Afferent Pharmaceuticals Drugs for Osteoarthritis Pain Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Afferent Pharmaceuticals Drugs for Osteoarthritis Pain Sales Growth Rate (2012-2017)

Figure Afferent Pharmaceuticals Drugs for Osteoarthritis Pain Sales Global Market Share (2012-2017

Figure Afferent Pharmaceuticals Drugs for Osteoarthritis Pain Revenue Global Market Share (2012-2017)

Table Astellas Pharma Basic Information List

Table Astellas Pharma Drugs for Osteoarthritis Pain Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Astellas Pharma Drugs for Osteoarthritis Pain Sales Growth Rate (2012-2017)

Figure Astellas Pharma Drugs for Osteoarthritis Pain Sales Global Market Share (2012-2017

Figure Astellas Pharma Drugs for Osteoarthritis Pain Revenue Global Market Share (2012-2017)

Table BioDelivery Sciences International Basic Information List

Table BioDelivery Sciences International Drugs for Osteoarthritis Pain Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure BioDelivery Sciences International Drugs for Osteoarthritis Pain Sales Growth Rate (2012-2017)

Figure BioDelivery Sciences International Drugs for Osteoarthritis Pain Sales Global Market Share (2012-2017

Figure BioDelivery Sciences International Drugs for Osteoarthritis Pain Revenue Global Market Share (2012-2017)

Table Crystal Genomics Basic Information List

Table Crystal Genomics Drugs for Osteoarthritis Pain Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Crystal Genomics Drugs for Osteoarthritis Pain Sales Growth Rate (2012-2017)

Figure Crystal Genomics Drugs for Osteoarthritis Pain Sales Global Market Share (2012-2017

Figure Crystal Genomics Drugs for Osteoarthritis Pain Revenue Global Market Share (2012-2017)

Table Cytori Therapeutics Basic Information List

Table Daiichi Sankyo Basic Information List

Table Eli Lilly Basic Information List

Table Endo Pharmaceuticals Holdings Basic Information List

Table Horizon Pharma Basic Information List

Table iCeutica Basic Information List

Table Iroko Pharmaceuticals Basic Information List

Table Merck Basic Information List

Table Nuvo Research Basic Information List

Table Regeneron Pharmaceuticals Basic Information List

Table Sanofi Basic Information List

Table SantoSolve Basic Information List

Table Techfields Pharma Basic Information List

Table Winston Pharmaceuticals Basic Information List

Table Yooyoung Pharmaceutical Basic Information List

Table Zynerba Pharmaceuticals Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Drugs for Osteoarthritis Pain

Figure Manufacturing Process Analysis of Drugs for Osteoarthritis Pain

Figure Drugs for Osteoarthritis Pain Industrial Chain Analysis

Table Raw Materials Sources of Drugs for Osteoarthritis Pain Major Players in 2016

Table Major Buyers of Drugs for Osteoarthritis Pain

Table Distributors/Traders List

Figure Global Drugs for Osteoarthritis Pain Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)

Figure Global Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Global Drugs for Osteoarthritis Pain Price (USD/Pcs) and Trend Forecast (2017-2022)

Table Global Drugs for Osteoarthritis Pain Sales Volume (K Pcs) Forecast by Regions (2017-2022)

Figure Global Drugs for Osteoarthritis Pain Sales Volume Market Share Forecast by Regions (2017-2022)

Figure Global Drugs for Osteoarthritis Pain Sales Volume Market Share Forecast by Regions in 2022

Table Global Drugs for Osteoarthritis Pain Revenue (Million USD) Forecast by Regions (2017-2022)

Figure Global Drugs for Osteoarthritis Pain Revenue Market Share Forecast by Regions (2017-2022)

Figure Global Drugs for Osteoarthritis Pain Revenue Market Share Forecast by Regions in 2022

Figure United States Drugs for Osteoarthritis Pain Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)

Figure United States Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure China Drugs for Osteoarthritis Pain Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)

Figure China Drugs for Osteoarthritis Pain Revenue and Growth Rate Forecast (2017-2022)

Figure Europe Drugs for Osteoarthritis Pain Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)

Figure Europe Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Japan Drugs for Osteoarthritis Pain Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)

Figure Japan Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Southeast Asia Drugs for Osteoarthritis Pain Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)

Figure Southeast Asia Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure India Drugs for Osteoarthritis Pain Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)

Figure India Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Table Global Drugs for Osteoarthritis Pain Sales (K Pcs) Forecast by Type (2017-2022)

Figure Global Drugs for Osteoarthritis Pain Sales Volume Market Share Forecast by Type (2017-2022)

Table Global Drugs for Osteoarthritis Pain Revenue (Million USD) Forecast by Type (2017-2022)

Figure Global Drugs for Osteoarthritis Pain Revenue Market Share Forecast by Type (2017-2022)

Table Global Drugs for Osteoarthritis Pain Price (USD/Pcs) Forecast by Type (2017-2022)

Table Global Drugs for Osteoarthritis Pain Sales (K Pcs) Forecast by Application (2017-2022)

Figure Global Drugs for Osteoarthritis Pain Sales Market Share Forecast by Application (2017-2022)

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370